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DObjective: Total cavopulmonary connection (TCPC) is rarely performed for a functional single ventricle in
children with Down syndrome; therefore, the postsurgical outcomes are not well known. We evaluated mortality
and related factors after TCPC in children with Down syndrome.
Methods: Between January 2004 and March 2010 we identified 8 patients with Down syndrome among 235
patients who had undergone TCPC. The preoperative clinical course, preoperative data, and postoperative
clinical course were evaluated. In addition, clinical parameters and postoperative clinical course were compared
between children with Down syndrome (n ¼ 8) and a non-Down syndrome group (n ¼ 227).
Results: The median age at the time of TCPC was 4.1 years (range, 3.4-5.5 years), and the preoperative mean
pulmonary artery pressure was 13.9  1.81 mm Hg. We observed respiratory complications in 2 patients, sur-
gical site infection in 3 patients, and chylothorax in 2 patients. No significant difference was observed in pre-
operative data and mortality rate (1 of 8 patients [12.5%] in the Down syndrome group; 5 of 227 patients
[2.2%] in the non-Down syndrome group) between the groups of children with and without Down syndrome.
However, when the postoperative clinical course was examined, the durations of intensive care unit stay
(P ¼ .009) and hospital stay (P ¼ .007) were found to be significantly prolonged in the Down syndrome group.
Conclusions: Patients with Down syndrome tend to show prolonged recovery after TCPC. However, as opposed
to previous reports, the mortality rate of patients undergoing TCPC is lower with no significant difference from
that of children without Down syndrome. (J Thorac Cardiovasc Surg 2013;146:1349-52)The Fontan operation for tricuspid atresia was first reported
in 1971. Subsequently, the operation was modified several
times and used for the treatment of other congenital heart dis-
eases associatedwith a single functional ventricle.1With im-
provements in treatment methods, the long-term prognosis
and quality of life of patients with a Fontan circulation is
gaining importance.2However, theFontanoperation is rarely
performed in childrenwithDown syndrome3-6; therefore, the
postoperative outcome for this group is not well known.
Patients with Down syndrome are at risk of developing
persistent pulmonary hypertension7 and airway obstruction,8
which may affect the outcome of univentricular repair. We
report the result of total cavopulmonary connection
(TCPC) performed in 8 children with Down syndrome.
METHODS
Patients
Between January 2004 and March 2010, 14 patients (11 boys and 3
girls) with Down syndrome among 240 total patients (120 boys and
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The Journal of Thoracic and Car(BCPS), whereas 8 patients with Down syndrome (6 boys and 2 girls)
among 235 patients (121 boys and 117 girls) underwent TCPC, excluding
TCPC conversion or repeat TCPC, at Sakakibara Heart Institute. All
patients underwent BCPS before TCPC during this period.
Clinical Protocol
We investigated children with Down syndrome who had undergone uni-
ventricular repair. In particular we took note of the clinical course after
BCPS and patient characteristics, preoperative catheter data, surgical
data, preoperative echocardiographic data, type of Fontan operation, post-
operative data and clinical course, and lung biopsy results. Postoperative
catheter data and mortality were evaluated after TCPC. Patient character-
istics, including clinical diagnosis, sex, age at TCPC, and body weight at
TCPC were also investigated. Preoperative catheter data, including oxygen
saturation, mean pulmonary artery pressure, and Nakata’s pulmonary ar-
tery index (PAI)9; and echocardiographic data, including aortic regurgita-
tion and atrioventricular valve regurgitation, were graded as 0 ¼ absent,
1 ¼ trivial, 2 ¼ mild, 3 ¼ moderate, or 4 ¼ severe. Postoperative data in-
cluded central venous pressure (CVP) on entry into the intensive care unit
(ICU), complications, index of pulmonary vascular disease,10 Heath–
Edwards classification as derived from lung biopsy examination,11 and
postoperative oxygen saturation and CVP.
In addition, diagnostic category, preoperative catheter data, type of
Fontan operation, postoperative data, clinical course, and mortality
were compared between patients with Down syndrome (Down syndrome
group, n ¼ 8) and those without (non-Down syndrome group, n ¼ 227).
Postoperative data and clinical course were evaluated for the 2 groups
with respect to the following parameters: CVP on entering the ICU,
frequency of nitric oxide use, repeat surgery rate, duration of mechanical
ventilation, duration of ICU stay, duration of pleural drainage, duration of
hospital stay, and mortality. Mortality was categorized as either hospital
death or late death (defined as death after discharge). We continued
postoperative follow-up until December 2012. We evaluated all the
above-mentioned parameters by performing a retrospective review of
each patient’s medical records.diovascular Surgery c Volume 146, Number 6 1349
••
FIGURE1. Cavopulmonary shunt and cavopulmonary connection in chil-
dren with Down syndrome. BCPS, Bidirectional superior cavopulmonary
shunt; TCPC, total cavopulmonary connection.
Congenital Heart Disease Furukawa et al
C
H
DStatistical Analyses
StatView version 5.0 software (SAS Institute, Inc, Cary, NC) was used
for all statistical analyses. The data are expressed as mean  standard
deviation. Statistical significance was defined as P<.05. We used nonpara-
metric tests to compare the parameters between the 2 groups. Differences in
count or percentage data between the 2 groups were evaluated using c2
analysis with Yates correction for continuity.
RESULTS
The clinical course of patients with Down syndrome who
received a BCPS is shown in Figure 1. Fourteen patients
with Down syndrome received a BCPS, with no hospital
deaths and 2 late deaths. One patient died a sudden death
4 months after BCPS, whereas the other died as a result
of heart failure 29 months after BCPS. Eight patients under-
went TCPC, and 4 patients are still awaiting TCPC.
In the 8 patients with Down syndrome who underwent
TCPC, the median age at the time of TCPC was 4.1 years
(range, 3.4-5.5 years) and the mean body weight was
13.1 kg (range, 9.6-15.0 kg). The preoperative mean pulmo-
nary artery pressure was 13.9  1.8 mm Hg, and PAI of all
patients was above 200 mm2/body surface area (in meters2)TABLE 1. Characteristics and preoperative data of patients in the Down
Patient Diagnosis Sex Age, y W
1 DORV, ASD, MS, Hypo-LV, CoA Boy 4.8
2 uAVSD, Hypo-LV, CoA, LVOTO Boy 2.4
3 SLV, CA, CoA Boy 5.5
4 VSD, ASD(II), Straddling MV, Straddling TV Boy 3.8
5 uAVSD, Hypo-RV Boy 4.3
6 uAVSD, Hypo-RV Boy 5.4
7 TOF, PA, uAVSD, Hypo-RV, PDA Girl 3.4
8 cAVSD, CoA, LVOTO Girl 3.8
SpO2, Oxygen saturation; PAP, pulmonary artery pressure; PAI, pulmonary artery index; A
right ventricle; ASD, atrial septul defect; MS, mitral stenosis; Hypo-LV, hypoplastic left ve
LVOTO, left ventricular outflow tract obstruction; SLV, single left ventricle;MV, mitral valv
PA, pulmonary atresia; PDA, patent ductus arteriosus; CA, common atrium; VSD, ventricu
1350 The Journal of Thoracic and Cardiovascular Sur(Tables 1 and 2). We observed respiratory complications in
2 patients, surgical site infection in 3 patients, and chylo-
thorax in 2 patients (Table 3). One patient (patient 2) died
suddenly on postoperative day (POD) 17 because of
a suspected pulmonary hypertension crisis. Results of
lung biopsy obtained at autopsy revealed Heath–Edwards
classification grade 3 and index of pulmonary vascular dis-
ease grade D. Therewere no late deaths in the other patients.
One patient developed protein-losing enteropathy 8 months
after TCPC.
As shown in Table 2, there was no significant difference
in preoperative data and diagnostic category between the
groups of children with and without Down syndrome. How-
ever, there was no case of hypoplastic left heart syndrome
and heterotaxy syndrome in the Down syndrome group.
Mortality was higher in the Down syndrome group (1 of 8
patients, 12.5%) than in the non-Down syndrome group
(5 of 227 patients, 2.2%), although this difference was
not statistically significant (Table 4). However, when the
postoperative clinical course was examined, the rate of ni-
tric oxide use (50.0% vs 7.9%; P<.001) and that of repeat
surgery (25.0% vs 2.6%; P ¼ .015) were higher in the
Down syndrome group than in the non-Down syndrome
group. Patient 6 underwent surgery for an enlarged fenestra-
tion at POD 1, whereas patient 7 underwent repeat TCPC at
POD 4. Furthermore, the duration of mechanical ventilation
(7.8  6.9 days vs 2.6  8.2 days; P ¼ .039), duration of
ICU stay (14.0  9.9 days vs 5.2  10.3 days; P ¼ .009),
duration of pleural drainage (17.0  14.7 days vs
9.7  10.3 days; P ¼ .027), and duration of hospital stay
(40.1  31.3 days vs 27.7  17.0 days; P ¼ .007) were
found to be significantly prolonged in the Down syndrome
group (Table 4).DISCUSSION
Our study showed that the incidence of mortality after
TCPC was 2.2% in the non-Down syndrome group and
12.5% (1 of 8 patients) in the Down syndrome group,syndrome group
eight, kg SpO2,%
Mean
PAP, mm Hg PAI, mm2/m2
AR,
grade
AVVR,
grade
13.2 81.9 15 274 0 2
9.6 80.1 11 305 0 2
14.4 89.0 15 490 0 1
10.8 84.2 14 319 0 2
11.3 79.8 13 240 0 0
15.0 79.4 13 394 0 2
13.0 76.6 13 251 1 2
14.7 74.0 17 447 1 1
R, aortic regurgitation; AVVR, atrioventricular valve regurgitation; DORV, double out
ntricle; CoA, coarctation of aorta; uAVSD, unbalanced atrioventricular septal defect;
e; TV, tricuspid valve; Hypo-RV, hypoplastic right ventricle; TOF, tetralogy of Fallot;
lar septal defect.
gery c December 2013
TABLE 2. Comparison of preoperative data between groups of
children with and without Down syndrome
Down
syndrome
(n ¼ 8)
No Down
syndrome
(n ¼ 227)
P
value
Boys, n (%) 6 (75) 115 (50.7) .320
Median age at TCPC operation,
y (range)
4.1 (34-5.5) 3.2 (1.0-45.5) .143
Median weight, kg (range) 13.1 (9.6-15.0) 12.9 (6.7-69.1) .136
Diagnostic categories, n (%)
Function single LV 4 (50) 75 (33.0) .537
Function single RV 2 (25) 52 (22.9) .772
HLHS 0 20 (8.8) .816
Heterotaxy syndrome 0 29 (12.7) .594
Others 2 (25) 51 (22.5) .793
Preoperative catheter
CVP, mm Hg 7.43  1.72 7.03  2.57 .344
mPAP, mm Hg 13.9  1.8 13.6  3.0 .384
PAI 340.0  93.2 282.3  118.4 .087
AR 0.25  0.46 0.20  0.46 .388
AVVR 1.50  0.76 0.98  0.99 .071
TCPC, Total cavopulmonary connection; LV, left ventricle; RV, right ventricle;HLHS,
hypoplastic left heart syndrome; CVP, central venous pressure; mPAP, mean pulmo-
nary artery pressure; PAI, pulmonary artery index; AR, aortic regurgitation; AVVR,
atrioventricular valve regurgitation.
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Dalthough there was no significant difference between the 2
groups. Gupta-Malhotra and colleagues3 studied 17 patients
with Down syndrome who underwent TCPC and reported
that mortality in the early period was 29% and significantly
higher than that in patients without Down syndrome (10%).TABLE 3. Postoperative data of patients with Down syndrome
Patient Type of operation
CVP,
mm Hg Complication
Respiration
problem
1 Fenestrated extracardiac
conduit
13 No No
2 Extracardiac conduit 13 No No
3 Extracardiac conduit 18 SSI
Chylothorax
Tracheostenos
4 Fenestrated extracardiac
conduit DKS, lung
biopsy
11 No No
5 Extracardiac conduit 15 Chylothorax No
6 Fenestrated extracardiac
conduit, PA plasty0
Re-fenestration (POD 1)
15 SSI No
7 Extracardiac conduit0
TCPC repair (POD 4)
14 Thrombosis No
8 Fenestrated extracardiac
conduit
15 SSI PLE Laryngomalac
Tracheal rin
CVP, Central venous pressure; SpO2, oxygen saturation; Pre-TCPC, preoperative total ca
Edwards classification; POD, postoperative day; SSI, surgical site infection; DKS, Damu
connection; PLE, protein losing enteropathy.
The Journal of Thoracic and CarThey argued that Down syndrome itself is a strong indepen-
dent factor of mortality. Our data indicate that there was no
significant difference in preoperative data such as mean
pulmonary artery pressure, PAI, aortic regurgitation, and
atrioventricular valve regurgitation between the 2 groups,
although the postoperative clinical course was prolonged
significantly in the patients with Down syndrome. There
were several patients inwhoma serious postoperative clinical
course was observed, and this could not be anticipated from
the preoperative catheter data. Furthermore, the rates of nitric
oxide use and repeat surgery were significantly high in the
Down syndrome group in our study. One patient died sud-
denly as a result of a suspected pulmonary hypertension cri-
sis, suggesting that it may be difficult to predict the outcome
of TCPC on the basis of preoperative catheter data.Wada and
colleagues5 reported the case of a patient who was awaiting
Fontan surgery after BCPS. Although all criteria of TCPC
had been fulfilled on the basis of preoperative hemodynamic
studies, histologic analysis revealed hypertrophyof the tunica
media in almost all preacinar small pulmonary arteries. Lung
biopsy is an effective means of determining the outcome of
TCPC in patients with Down syndrome.
Children with Down syndrome have a higher incidence
of tracheal bronchus, abnormal segmental bronchial
branching, laryngomalacia, and tracheomalacia.8 In our re-
port, 2 of 8 patients developed respiratory tract disease as
a complication, which was a reason for their long-term
mechanical ventilation and prolonged ICU stay. There is
evidence of a high incidence of chylothorax after FontanLung biopsy
Postoperative catheter
OutcomeSpO2,%
CVP,
mm Hg
Pre-TCPC IPVD 1.0, HE 1 82.8 14 Alive (38 mo)
Autopsy IPVD 1.7, HE 3 Not done Sudden death
(POD 17)
is Not done 91.0 17 Alive (96 mo)
At TCPC IPVD 1.0, HE 1 90.0 10 Alive (42 mo)
Not done 94.0 14 Alive
(85 months)
Not done Not done Alive (27 mo)
Not done 92.0 12 Alive (19 mo)
ia
g
Not done 94.5 11 Alive (19 mo)
vopulmonary connection; IPVD, index of pulmonary vascular disease; HE, Heath-
s-Kaye-Stansel operation; PA, pulmonary artery plasty; TCPC, total cavopulmonary
diovascular Surgery c Volume 146, Number 6 1351
TABLE 4. Comparison of intraoperative and postoperative data for
children with and without Down syndrome
Down
syndrome
(n ¼ 8)
No Down
syndrome
(n ¼ 227)
P
value
Fontan type .031*
Extracardiac nonfenestrated 4 (50.0) 193 (85.0)
Extracardiac fenestrated 4 (50.0) 34 (15.0)
CVP after Fontan surgery 14.3  2.1 13.7  2.1 .217
Nitric oxide 4 (50.0) 18 (7.9) <.001*
Repent surgery 2 (25.0) 6 (2.6) .015*
Duration of mechanical ventilation, d 7.8  6.9 2.6  3.2 .039*
Duration of ICU stay, d 14.0  9.9 5.2  10.3 .009*
Duration of pleural drainage, d 17.0  14.7 9.7  10.3 .027*
Duration of hospital stay, d 40.1  31.3 27.7  17.0 .007*
Death 1 (12.5) 5 (2.2) .500
Hospital death 1 (12.5) 4 (1.8)
Late death 0 1 (0.4)
Values are presented as n (%) or mean  standard deviation. CVP, Central venous
pres sure; ICU, intensive care unit. *P<.05.
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Dsurgery in children with Down syndrome,6 with Campbell
and colleagues4 reporting this complication in 3 of 4 pa-
tients. In our study, 2 of 8 patients developed chylothorax
that tended to prolong the duration of pleural drainage.
Furthermore, 3 patients (37.5%) developed surgical site
infection. Down syndrome is associated with an increased
frequency of infection, and several studies have reported
immunologic dysfunction to be associated with Down syn-
drome.12-14 Abnormalities of the innate immune system and
the prolonged duration of pleural drainage would be
expected to predispose patients to surgical site infection
and prolonged hospital stay.
In our study, only 8 patients with Down syndrome under-
went TCPC, with the duration of follow-up being short.
Various other complications are associated with Down
syndrome, such as obstructive sleep apnea syndrome,15 obe-
sity,16 recurrent lower respiratory tract infections, and gastro-
esophageal reflux.17 Approximately 50% of children with
Down syndrome develop obstructive sleep apnea syndrome,
which may contribute to the unexplained pulmonary hyper-
tension associated with Down Syndrome.18 Gastroesopha-
geal reflux, pulmonary aspiration, and lower respiratory
tract infections also increase the risk of pulmonary hyperten-
sion in these patients,19 and it is possible that they contribute
to the development of this complication after TCPC. A long-
term follow-up study with a larger number of patients with
Down syndrome is therefore required, and it is also necessary
to further evaluate the outcome of TCPC in these patients.
Study Limitations
Ours was a retrospective study with a short follow-up
duration. In addition, the number of patients with Down
syndrome was only 8 and significantly lower than that of1352 The Journal of Thoracic and Cardiovascular Surpatients without Down syndrome; this may have limited
the results of the statistical evaluation of this study.
Moreover, we made no mention of early palliative care in
this investigation of univentricular repair.
CONCLUSIONS
We reported on 8 patients with Down syndrome who un-
derwent TCPC. One of those 8 patients died after TCPC,
whereas the clinical course and recovery after surgery in
the other 7 patients was significantly prolonged. On the ba-
sis of these findings we consider it necessary to study more
cases to evaluate mortality and long-term prognosis.
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